malondialdehyde has been researched along with Central Serous Chorioretinopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behar-Cohen, F; Berthet, A; Danuser, B; Daruich, A; Eperon, S; Matet, A; Sauvain, JJ; Schweizer, C | 1 |
1 other study(ies) available for malondialdehyde and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
Levels of the oxidative stress biomarker malondialdehyde in tears of patients with central serous chorioretinopathy relate to disease activity.
Topics: Adult; Aminoacridines; Biomarkers; Case-Control Studies; Central Serous Chorioretinopathy; Female; Humans; Male; Malondialdehyde; Middle Aged; Multivariate Analysis; Oxidative Stress; Retinal Detachment; Tears; Thiobarbiturates; Tomography, Optical Coherence | 2020 |